Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503594-38-00

Acronym

M23-647

Enrollment

Registered

2024-05-22

Start date

2024-07-15

Completion date

Unknown

Last updated

2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Select B-Cell malignancies.

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026